Showing results (1-10 of 254) with videos related to
Sort By:
Pageof 26
Therapeutic Advances in Medical Oncology|July 27, 2011
Targeted therapy in renal cancerTanya B Dorff, Amir Goldkorn, David I QuinnExpert Review of Clinical Pharmacology|December 7, 2013
Novel tyrosine kinase inhibitors for renal cell carcinomaTanya B Dorff, Sumanta K Pal, David I QuinnOncotargets and Therapy|October 8, 2016
Clinical use of cabozantinib in the treatment of advanced kidney cancer: efficacy, safety, and patient selectionSteven S Yu, David I Quinn, Tanya B DorffBiologics : Targets & Therapy|June 22, 2013
Tivozanib in the treatment of renal cell carcinomaMehmet Hepgur, Sarmad Sadeghi, Tanya B Dorff, et al.BMC Cancer|December 18, 2014
Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic reviewVishal Vashistha, David I Quinn, Tanya B Dorff, et al.Maturitas|May 31, 2011
Vaccine therapy with sipuleucel-T (Provenge) for prostate cancerEddie Thara, Tanya B Dorff, Jacek K Pinski, et al.Human Vaccines & Immunotherapeutics|February 29, 2012
Blood cells and their use in active immunotherapy of prostate cancerShuang Yin Zhang, Eddie Thara, David I Quinn, et al.Seminars in Oncology|October 9, 2012
Small cell bladder cancer: biology and managementElie Fahed, Donna E Hansel, Derek Raghavan, et al.Clinical Advances in Hematology & Oncology : H&O|July 28, 2017
Immunotherapy in urothelial cancer, part 1: T-cell checkpoint inhibition in advanced or metastatic diseaseSteven S Yu, Tanya B Dorff, Leslie K Ballas, et al.Urologic Oncology|November 19, 2013
Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: a critical analysis of 1,994 patientsAnirban P Mitra, Eila C Skinner, Anne K Schuckman, et al.Pageof 26